Skip to main content
. 2023 May 22;11(3):e04368-22. doi: 10.1128/spectrum.04368-22

TABLE 2.

RSV single versus co-infections

Population Single RSV infection
RSV co-infection
N (%) N (%)
n 63 n 47 P
General characteristicsb
 Male sex (n, %) 32 63 (50.8) 36 47 (76.6) 0.01 c
 Prematurity (n, %) 8 63 (12.7) 3 47 (6.4) 0.35
 Small for gestational age (n, %) 6 62a (9.7) 4 47 (8.5) 1
 Daycare attendance (n, %) 24 62a (38.7) 32 43a (74.4) <0.001
 Breast feeding (n, %) 40 63 (63.5) 25 47 (53.2) 0.28
 Parental atopy (n, %) 6 61a (9.8) 12 44a (27.3) 0.02
 Parental smoking (n, %) 12 59a (20.3) 17 44a (38.6) 0.04
 Age 3.3 1.6-8.8 5.8 3.9 to 11.2 0.03
Clinical parameters
 Dyspnea (n, %) 43 63 (68.3) 39 47 (83) 0.08
 Anorexia (n, %) 51 63 (81) 38 47 (80.9) 0.99
 Fever (n, %) 50 63 (79.4) 40 47 (85.1) 0.44
 Cyanosis (n, %) 3 63 (4.8) 2 47 (4.3) 1
 Tachypnea on admission (n, %) 42 63 (66.7) 28 47 (59.6) 0.44
 Tachycardia on admission (n, %) 20 63 (32.3) 13 47 (27.7) 0.61
Primary outcome measuresd
 PICU admission (n, %) 17 63 (27) 3 47 (6.4) 0.01
 Duration of hospitalization (days, median, Q1 to Q3) 4 3 to 7 3 2 to 5 0.02
 Desaturation on admission (n, %) 17 63 (27) 8 47 (17) 0.22
 O2 administration (n, %) 41 63 (65.1) 24 47 (51.1) 0.14
 BRAS (median, Q1 to Q3) 3 2 to 4 2 1 to 3 0.01
Secondary outcome measures
 Duration of O2 administration (days; median, Q1 to Q3) 3 1.5 to 5 2 1 to 4.875 0.49
 Maximum O2 flow (l/min; median, Q1 to Q3) 8 1 to 12.5 1.5 1 to 14 0.73
 Maximum FiO2 (%, median Q1 to Q3) 28 24 to 47 24 24 to 30 0.16
 Intubation (n, %) 3 63 (4.8) 0 47 (0) 0.26
 ReSVinet score (median, Q1 to Q3) 9 5 to 12 8 5 to 11 0.43
a

Data are lacking for some patients.

b

Statistical analysis was performed using Pearson's chi-squared, Fisher’s exact, or Mann-Whitney-U test, as appropriate.

c

Significant P-values in bold.

d

PICU, pediatric intensive care unit; BRAS, Bronchiolitis Risk of Admission Score; FiO2, fraction of inspired oxygen; .